Upstate Active Clinical Trials Seeking Participants
Study title
A Double-blind, Placebo-controlled Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates with Enteroviral Sepsis Syndrome.
IRB number
3952F
What is the purpose of the study?
To determine if administration of a new drug called Pleconaril helps in treating babies with Enteroviral Sepsis.
Who is eligible?
For infants with enteroviral sepsis who are 15 days or less of age when they get sick.
What is involved if I participate?
- How long is the study?
Study medication for 7 days. Follow-up visits at days 10 & 14, months 2, 6, 12,18 and 24. - Is transportation provided or reimbursed?
Yes - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Physical exams, blood samples, urine samples, stool samples and echocardiogram.
Who is the doctor administering the study?
Dr. Leonard B. Weiner
Where will the study take place?
SUNY Upstate Medical University,
Syracuse, NY,
Crouse Hospital, Syracuse, NY
Over what time period is the study scheduled to run?
completed
Who can I contact for more information?
- Name: Beatriz Kovar
- Phone: (315) 464-7511
- Email: Kovarb@upstate.edu
- Fax: (315) 464-7812
If you are interested in this trial, please contact the study coordinator or investigator noted above.
